Clik here to view.
Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR
Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry...
View ArticleClik here to view.
BIO’s Prometheus v. Mayo Amicus Brief Filed
BIO filed an amicus brief in the Prometheus v. Mayo Clinic case. In this case the Supreme Court is being asked to decide whether diagnostic and personalized medicine claims that depend on a...
View ArticleClik here to view.
Supreme Court Decision on Web Content Delivery to Impact Biotech Patents
Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued a decision that will likely impact patents directed to methods for treating or diagnosing...
View ArticleClik here to view.
Supreme Court Enunciates New Indefiniteness Standard
The Supreme Court has once again reversed a decision by the Federal Circuit, in this case involving the proper standard for finding claims indefinite. The case, Nautilus, Inc. v. Biosig Instruments,...
View ArticleClik here to view.
Patent Cases Down by 40% in 2014
The number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. This trend has some questioning whether Congressional patent reform is...
View ArticleBIO Reacts to Supreme Court opinion in Impression Products, Inc. v. Lexmark...
On Tuesday, May 30, 2017, the U.S. Supreme Court issued an opinion in Impression Products, Inc. v. Lexmark International, Inc. As mentioned in our previous post on this case, the issue before the...
View Article
